Company / Inventory per Share
Vertex Pharmaceuticals Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$6.56
FY2025
5-year range
$1.36 / $6.56
FY2021-FY2025
Trend
+40.3%
vs FY2024
Sector context
#13 of 105
Health Care
What the data says
Vertex Pharmaceuticals's inventory per share of $6.56 is higher than 88% of companies in the Health Care sector (FY2025). Inventory per Share has increased for 9 consecutive years, from $0.32 in FY2016 to $6.56 in FY2025.
Based on SEC 10-K filings.
6.56 in FY2025 with a 5-year CAGR of +43.4%. Top quartile in the Health Care sector.
Improved from $2.87 to $6.56 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +53.6%
- 5-Year CAGR
- +43.4%
- 10-Year CAGR
- -
Sector benchmark
-78.7% below sector average
Key checks
Key Insights
- Vertex Pharmaceuticals's inventory per share has grown for 9 consecutive years.
- In FY2025, inventory per share increased 40.3% year-over-year.
- Ranks #13 out of 105 companies in the Health Care sector.
- Lowest inventory per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.56 | +40.3% |
| FY2024 | $4.68 | +62.7% |
| FY2023 | $2.87 | +58.8% |
| FY2022 | $1.81 | +33.2% |
| FY2021 | $1.36 | +25.3% |
| FY2020 | $1.08 | +65.2% |
| FY2019 | $0.66 | +33.7% |
| FY2018 | $0.49 | +9.0% |
| FY2017 | $0.45 | +42.9% |
| FY2016 | $0.32 | +33.2% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026